These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 19725378)

  • 21. [Vaccination against cervical cancer and diseases caused by Human Papillomavirus].
    Bornstein J; Tuma R; Zarfati D; Ophir E
    Harefuah; 2007 Oct; 146(10):764-9, 814. PubMed ID: 17990391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The current and future role of screening in the era of HPV vaccination.
    Myers E; Huh WK; Wright JD; Smith JS
    Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
    Saslow D; Wheeler CM
    Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccines against human papillomavirus: perspectives for controlling cervical cancer.
    García Carrancá A; Galván SC
    Expert Rev Vaccines; 2007 Aug; 6(4):497-510. PubMed ID: 17669005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.
    Bosch FX; Tsu V; Vorsters A; Van Damme P; Kane MA
    Vaccine; 2012 Nov; 30 Suppl 5():F1-11. PubMed ID: 23199951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction of human papillomavirus vaccines into developing countries - international strategies for funding and procurement.
    Andrus JK; Sherris J; Fitzsimmons JW; Kane MA; Aguado MT
    Vaccine; 2008 Aug; 26 Suppl 10():K87-92. PubMed ID: 18847561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
    Koulova A; Tsui J; Irwin K; Van Damme P; Biellik R; Aguado MT
    Vaccine; 2008 Dec; 26(51):6529-41. PubMed ID: 18805453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries.
    Steben M; Jeronimo J; Wittet S; Lamontagne DS; Ogilvie G; Jensen C; Smith J; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F183-91. PubMed ID: 23199962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age considerations when vaccinating against HPV.
    Wright TC; Huh WK; Monk BJ; Smith JS; Ault K; Herzog TJ
    Gynecol Oncol; 2008 May; 109(2 Suppl):S40-7. PubMed ID: 18482558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons from the failure of human papillomavirus vaccine state requirements.
    Schwartz JL; Caplan AL; Faden RR; Sugarman J
    Clin Pharmacol Ther; 2007 Dec; 82(6):760-3. PubMed ID: 17971822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary and secondary prevention of cervical cancer.
    Grce M
    Expert Rev Mol Diagn; 2009 Nov; 9(8):851-7. PubMed ID: 19895230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccines.
    Hildesheim A; Markowitz L; Avila MH; Franceschi S
    Vaccine; 2006 Aug; 24 Suppl 3():S3/227-32. PubMed ID: 16950011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.
    Franco EL; Tsu V; Herrero R; Lazcano-Ponce E; Hildesheim A; Muñoz N; Murillo R; Sánchez GI; Andrus JK
    Vaccine; 2008 Aug; 26 Suppl 11():L88-95. PubMed ID: 18945406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparing for HPV vaccination in South Africa: key challenges and opinions.
    Harries J; Moodley J; Barone MA; Mall S; Sinanovic E
    Vaccine; 2009 Jan; 27(1):38-44. PubMed ID: 18977271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papilloma virus vaccination for control of cervical cancer: a challenge for developing countries.
    Bello FA; Enabor OO; Adewole IF
    Afr J Reprod Health; 2011 Mar; 15(1):25-30. PubMed ID: 21987934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advisory report from the Health Council of the Netherlands to include human papillomavirus vaccination in the national immunisation programme for the prevention of cervical cancer].
    Boeke AJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):981-3. PubMed ID: 18549170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.